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MaOBJECTIVES This study sought to evaluate pattern and clinical correlates of change in left ventricular (LV) geometry
over a 4-year period in the community; it also assessed whether the pattern of change in LV geometry over 4 years
predicts incident cardiovascular disease (CVD), including myocardial infarction, heart failure, and cardiovascular death,
during an additional subsequent follow-up period.
BACKGROUND It is unclear how LV geometric patterns change over time and whether changes in LV geometry have
prognostic signiﬁcance.
METHODS This study evaluated 4,492 observations (2,604 unique Framingham Heart Study participants attending
consecutive examinations) to categorize LV geometry at baseline and after 4 years. Four groups were deﬁned on the basis
of the sex-speciﬁc distributions of left ventricular mass (LVM) and relative wall thickness (RWT) (normal: LVM and
RWT <80th percentile; concentric remodeling: LVM <80th percentile but RWT$80th percentile; eccentric hypertrophy:
LVM $80th percentile but RWT <80th percentile; and concentric hypertrophy: LVM and RWT $80th percentile).
RESULTS At baseline, 2,874 of 4,492 observations (64%) had normal LVM and RWT. Participants with normal geometry
or concentric remodeling progressed infrequently (4% to 8%) to eccentric or concentric hypertrophy. Change from
eccentric to concentric hypertrophy was uncommon (8%). Among participants with concentric hypertrophy, 19%
developed eccentric hypertrophy within the 4-year period. Among participants with abnormal LV geometry at baseline, a
signiﬁcant proportion (29% to 53%) reverted to normal geometry within 4 years. Higher blood pressure, greater body
mass index (BMI), advancing age, and male sex were key correlates of developing an abnormal geometry. Development
of an abnormal LV geometric pattern over 4 years was associated with increased CVD risk (140 events) during a
subsequent median follow-up of 12 years (adjusted-hazards ratio: 1.59; 95% conﬁdence interval: 1.04 to 2.43).
CONCLUSIONS The longitudinal observations in the community suggest that dynamic changes in LV geometric pattern
over time are common. Higher blood pressure and greater BMI are modiﬁable factors associated with the development of
abnormal LV geometry, and such progression portends an adverse prognosis. (J Am Coll Cardiol Img 2014;7:870–8)
© 2014 by the American College of Cardiology Foundation.m the *Framingham Heart Study, Framingham, Massachusetts; yInstitute of Epidemiology, Christian-Albrechts-University
l, Kiel, Germany; zUniversity of Massachusetts Boston, Boston, Massachusetts; xDepartment of Mathematics and Statistics,
ston University, Boston, Massachusetts; kBoston Veterans Affairs Health Care System, West Roxbury, Massachusetts; {Harvard
dical School, Boston, Massachusetts; #Medical University of South Carolina and Department of Veterans Affairs Medical,
arleston, South Carolina; **Division of Cardiovascular Medicine, Brigham and Women’s Hospital, Boston, Massachusetts;
hitaker Cardiovascular Institute, Preventive Medicine and Cardiology Sections, Boston University School of Medicine, Boston,
ssachusetts; and the zzDepartment of Epidemiology, Boston University School of Public Health, Boston, Massachusetts.
is work was supported by the National Heart, Lung, and Blood Institute’s and Boston University’s Framingham Heart
dy (contract no. N01-HC-25195) and grants R01HL080124 (Dr. Vasan) and K99HL10762 (Dr. Cheng) and 6R01-NS 17950.
. Cheng was in part supported by a grant from the Ellison Foundation. All other authors have reported that they have
relationships relevant to the contents of this paper to disclose.
nuscript received January 22, 2014; revised manuscript received May 6, 2014, accepted May 12, 2014.
AB BR E V I A T I O N S
AND ACRONYM S
ASE = American Society of
Echocardiography
BMI = body mass index
BP = blood pressure
CHD = coronary heart disease
CVD = cardiovascular disease
LV = left ventricular
LVEDD = left ventricular end-
diastolic diameter
LVH = left ventricular
hypertrophy
LVM = left ventricular mass
OR = odds ratio
RWT = relative wall thickness
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871T he left ventricle (LV) remodels over the lifecourse as an adaptive response to aging,exposure to cardiovascular disease (CVD)
risk factors, and myocardial injury (1). Left ventricu-
lar mass (LVM) and relative wall thickness (RWT) (ra-
tio of LV wall thickness and LV internal dimensions)
are important echocardiographic measures of LV
remodeling. Different LV geometric patterns can be
distinguished on the basis of whether RWT and LVM
are normal versus increased: normal geometry (LVM
and RWT are normal), concentric remodeling
(increased RWT but normal LVM), concentric hyper-
trophy (LVM and RWT are increased), and eccentric
hypertrophy (increased LVM with normal RWT) (2).
Both increased LVM (3,4) and abnormal LV geometry
patterns (5) adversely affect prognosis and are associ-
ated with impaired cardiac systolic and diastolic dys-
function (6), as well as with increased risk of CVD
events and all-cause mortality prospectively (5,7–10).SEE PAGE 879Information is very limited regarding how LV
geometric patterns change over time and the de-
terminants of such change. Furthermore, it is unclear
whether changes in LV geometric patterns antedate
the development of CVD, including heart failure. In
animal models, a temporal sequence of change in
LV geometric patterns has been observed, with
concentric hypertrophy leading to LV dilation and
eventually to overt heart failure (11). However, epide-
miological evidence for such sequential changes in
LV geometric patterns in the community is scant.
Speciﬁcally, it is unclear whether concentric hyper-
trophy changes to eccentric hypertrophy (which can
result from signiﬁcant LV dilation or from an increase
in LVM without signiﬁcant concentricity or LV dila-
tion) (12,13).The correlates and prognosis associated
with such changes in LV geometry are also unknown.
The authors hypothesized that exposure to multi-
ple cardiovascular risk factors adversely inﬂuences
the natural history of LV geometry. They also
hypothesized that worsening of LV geometry is
associated with increased risk of CVD.
METHODS
STUDY SAMPLE. The recruitment and phenotyping
of the Framingham Offspring Study have been
described elsewhere (14). At each quadrennial visit,
participants undergo a targeted medical history and
physical examination, standardized anthropometry,
and laboratory measurement of CVD risk factors.
Attendees at examination cycles 4, 5, and 6 were
eligible for the present investigation if they attendedconsecutive examinations and had available
echocardiograms. The authors excluded per-
sons with prevalent myocardial infarction or
heart failure at these examinations (n ¼ 490).
The study protocols were approved by the
Boston University Medical Center Institu-
tional Review Board. The study complies
with the Declaration of Helsinki. Written
informed consent has been obtained from the
participants.
ECHOCARDIOGRAPHIC MEASUREMENTS.
Echocardiograms were routinely obtained
at Offspring examination cycles 4 (1987 to
1990), 5 (1991 to 1995), and 6 (1996 to 1998)
as described previously and detailed in the
Online Appendix (15). Four groups were
deﬁned on the basis of the sex-speciﬁc dis-
tributions of LVM and RWT: normal LV geometry
(LVM and RWT <80th percentile), concentric
remodeling (LVM <80th percentile but RWT $80th
percentile), eccentric hypertrophy (LVM $80th
percentile but RWT <80th percentile), and concentric
hypertrophy (LVM and RWT $80th percentile). For
each participant, the LV geometric pattern at baseline
was compared with the pattern at the subsequent
examination approximately 4 years later. To maxi-
mize statistical power, the authors pooled observa-
tions on the changes in LV geometry from
examination cycle 4 to 5 and from cycle 5 to 6 (cross-
sectional pooling, Figure 1). If a participant had
echocardiograms done at examinations 4, 5, and 6,
that person was included twice in the analyses: once
describing the change from examination 4 to exami-
nation 5 (using examination 4 as the baseline) and the
second describing the change from examination 5 to
examination 6 (using examination 5 as the baseline).
The authors used this pooling approach to increase
precision of estimates and improve statistical power.
Left ventricular hypertrophy (LVH) and abnormal
RWT were deﬁned as values greater than the respec-
tive 80th sex-speciﬁc percentile at examination cycle
4 in those participants with available echocardio-
graphic data (for men: LVM, 207 g and RWT, 0.419; for
women: LVM, 170 g and RWT, 0.435). These reference
values were also applied to examination cycles 5 and
6. In additional analyses, the authors used cut-points
for LVH (LVM indexed to body surface area; #115 g/m2
vs. >115 g/m2 for men and #95 g/m2 vs. >95 g/m2
for women) and increased RWT (#0.42 vs. >0.42)
as published by the American Society of Echocardi-
ography (ASE) (16). Because analyses on the basis
of the ASE cut-points and those based on the 80th
percentile cut-points yielded similar rates of transi-
tion, all analyses focused on the latter approach.
FIGURE 1 Study Design and Principal Analyses
CVD is deﬁned as myocardial infarction, heart failure, or death from CHD. CHD ¼ coronary heart disease; CVD ¼ cardiovascular disease;
LV ¼ left ventricular.
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872ASSESSMENT OF CARDIOVASCULAR EVENTS. All
participants are under surveillance for the develop-
ment of CVD events including myocardial infarction,
heart failure, and death from coronary heart disease
(CHD). The diagnostic criteria for heart failure,
myocardial infarction, and death from CHD have been
described previously (17,18).
STATISTICAL METHODS. Differential missingness and
survival bias according to baseline LV geometric pattern.
During the 4-year period between consecutive ex-
amination cycles, approximately 1.3% (examination
cycle 4/5) to 1.4% (examination cycle 5/6) of par-
ticipants died; 6.5% (examination cycle 4/5) to 7.7%
(examination cycle 5/6) did not attend the follow-up
examination; and 16.6% (examination cycle 4/5) to
13.9% (examination cycle 5/6) of participants did
attend the follow-up examination, but no echocar-
diographic data could be obtained. More details are
provided in the Online Appendix.
Transition matrix. A transition matrix was constructed
to cross-classify LV geometry at the baseline and
subsequent examinations (cycles 4 to 5 and cycles
5 to 6, respectively, with cycles 4 and 5 serving as the
baselines [time 0] for this analysis) to assess theproportion of participants who remained in the same
category or developed a different geometric pattern
at follow-up. Because rates of change in LV geometry
were fairly similar from examination cycle 4 to 5
and from examination cycle 5 to 6, the authors
pooled data across these consecutive examinations
(Figure 1, label A).
Polytomous regression models. To evaluate clinical
covariates associated with change in LV geometric
patterns over time (Figure 1, label B), the authors used
polytomous regression models to estimate odds ratios
(ORs) and 95% conﬁdence intervals for each abnormal
geometric pattern (concentric remodeling, concentric
hypertrophy, eccentric hypertrophy) on follow-up,
with normal geometry at follow-up serving as a
referent group. The authors focused on participants
with a normal LV geometric pattern at baseline
because most observations fell into this group. This
study included sex, baseline age, systolic blood pres-
sure (BP), body mass index (BMI), antihypertensive
treatment, current smoking, diabetes, change in
systolic BP and change in BMI (from baseline to
follow-up), and the examination cycle as cova-
riates. Furthermore, in those participants with an
abnormal LV geometric pattern at baseline (concentric
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873remodeling, concentric hypertrophy, eccentric hy-
pertrophy), the authors estimated ORs for the rever-
sion to a normal LV geometric pattern on follow-up,
with “remaining in the respective abnormal baseline
category” serving as the referent category. These ORs
were adjusted for the same set of covariates noted
earlier.
Graphic display of changes in blood pressure, body mass
index, left ventricular mass, and relative wall thickness. In
participants with normal LV geometry at baseline, the
authors displayed changes in LVM and RWT stratiﬁed
by the LV geometric pattern on follow-up (Online
Figure 1A). To elucidate the inﬂuence of BP and BMI,
the change in these measures from baseline to follow-
up was displayed graphically (Online Figure 1B).
Association of change in left ventricular geometry with
cardiovascular disease (composite of incident myocardial
infarction, heart failure, and death from CHD). The
authors assessed whether change in LV geometry
from examination cycle 5 to 6 was associated with
incidence of CVD after examination cycle 6 (Figure 1,
label C; examination cycle 6 serving as the baseline
[time 0] for this analysis). For this purpose, partici-
pants were classiﬁed on the basis of how their
LV geometry changed from cycle 5 to cycle 6 and
4 groups were deﬁned:
1. Reference group: These participants with normal
geometry or concentric remodeling at examination
5 remained in the same category.
2. Improvement of LV geometry: These participants
reverted to normal geometry from any ab-
normal pattern at examination 5 or changed from
eccentric or concentric hypertrophy to concentric
remodeling.
3. Worsening of LV geometry: These participants
developed an abnormal geometric pattern from a
normal or concentric remodeling pattern. In addi-
tion, changes from eccentric to concentric LVH or
vice versa were considered as worsening.
4. Remained high risk: Participants with concentric
or eccentric hypertrophy who remained in the
same category were considered as a separate
category because these participants are at partic-
ularly high risk of CVD.
Cox proportional hazards regression models,
adjusted for age and sex, were used to relate the
change in LV geometry (independent categorical
variable as deﬁned earlier) to the incidence of CVD
after examination cycle 6 (dependent variable), after
conﬁrming that the assumption of the proportionality
of hazards was met. A composite endpoint was cho-
sen because LV geometry has been previously related
to all 3 components (myocardial infarction, heartfailure, and death from CHD), and to maximize sta-
tistical power.
The authors performed sensitivity analyses
deﬁning LV geometric patterns on the basis of ASE
cut-points. All analyses were performed using
SAS version 9.3 (SAS Institute Inc., Cary, North
Carolina); a 2-tailed p < 0.05 was considered statis-
tically signiﬁcant.
RESULTS
The baseline characteristics of this sample (4,492
observations, 2,604 unique participants; mean age,
51 years; 59% women) by LV geometry pattern are
shown in Table 1. The 2,604 participants (contrib-
uting 4,492 observations) represent 79% of the total
number of participants who attended examination
cycles 4, 5, and 6 (n ¼ 3,289). Participants with
eccentric and concentric hypertrophy were older
and had higher BP and BMI compared with partici-
pants with normal LV geometry or concentric
remodeling.
TRANSITION RATES OF LEFT VENTRICULAR GEO-
METRIC PATTERN DURING A 4-YEAR FOLLOW-UP
PERIOD. Most participants with normal LV geometry
at baseline remained in that category (68%); approx-
imately 20% progressed to concentric remodeling,
but transition to eccentric or concentric hypertrophy
was uncommon (Table 2, ﬁrst row). More than one-
half of the participants with concentric remodeling
at baseline had normal LV geometry at follow-up,
one-third remained in the concentric remodeling
category, and only 6% to 7% progressed to eccentric
and concentric hypertrophy (Table 2, second row).
More than 40% of participants with eccentric hyper-
trophy at baseline had normal geometry at follow-up,
whereas the development of concentric geometry was
relatively uncommon (8%) (Table 2, third row).
Approximately 19% of participants with concentric
hypertrophy at baseline changed to eccentric hyper-
trophy, 29% reverted to normal LV geometry, and 17%
reverted to concentric remodeling on follow-up
(Table 2, last row). When ASE cut-points were used
to deﬁne increased LVM and RWT, the proportion of
participants changing from concentric hypertrophy to
eccentric hypertrophy was lower (13%), but overall
the transition matrix on the basis of ASE cut-points
was not dissimilar (Online Table 1). The develop-
ment of eccentric hypertrophy can result from an
increase in left ventricular end-diastolic diameter
(LVEDD) (“dilated LVH”) (13), or it can be caused by
an increase in LVM, but without either signiﬁcant
increase in LVEDD or increased concentricity (“inde-
terminate LVH”) (12,13). To assess which subform of
TABLE 2 Transition
Baseline LV
Geometric Patt
Normal geometry (n ¼
Concentric remodeling
Eccentric hypertrophy
Concentric hypertrophy
Values are % (n).
LV ¼ left ventricular; n ¼
TABLE 1 Baseline Characteristics of the Study Sample by Baseline LV Geometry
Baseline LV Geometric Pattern
Normal
Geometry
(n ¼ 2,874)
Concentric
Remodeling
(n ¼ 820)
Eccentric
Hypertrophy
(n ¼ 590)
Concentric
Hypertrophy
(n ¼ 208)
Clinical features
Women 59 61 62 34
Age, yrs 50  10 54  9 51  10 58  9
Systolic BP, mm Hg 121  17 127  18 128  19 137  20
Diastolic BP, mm Hg 75  10 77  10 78  10 80  11
Antihypertensive treatment 10 18 17 35
Body mass index, kg/m2 25.7  4.0 26.2  3.9 28.2  5.1 29.3  4.4
Smoking 19 20 19 17
Diabetes 3 5 6 12
LV echocardiographic features
LV mass (crude), g 147  31 150  25 201  27 223  39
Relative wall thickness 0.37  0.04 0.47  0.04 0.39  0.03 0.49  0.07
End-diastolic diameter, cm 4.80  0.37 4.37  0.30 5.26  0.36 4.90  0.31
Fractional shortening 0.36  0.07 0.37  0.07 0.36  0.06 0.38  0.06
Values are % for binary traits or mean  SD for continuous traits.
BP ¼ blood pressure; LV ¼ left ventricular; n ¼ number of observations.
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874eccentric hypertrophy dominates in this sample,
the authors evaluated the change in LVEDD from
baseline to follow-up in those participants who
evolved from concentric to eccentric hypertrophy. As
expected, the majority of participants (34 of 39; 87%)
had an increase in LVEDD (Online Table 2).
CLINICAL CORRELATES OF CHANGE IN LV GEO-
METRY. Increasing age, male sex, higher systolic BP,
and greater BMI emerged as key correlates of abnor-
mal LV geometry on follow-up (Table 3). Smoking and
diabetes were also associated with increased odds of
developing an abnormal LV geometric pattern, but
only the association of diabetes with the develop-
ment of concentric remodeling reached statistical
signiﬁcance. In those participants with an abnormal
LV geometric pattern at baseline (concentric remod-
eling, concentric hypertrophy, and eccentric hyper-
trophy) (Online Table 3), male sex, older age, andRates of LV Geometric Pattern During a Mean Follow-Up of 4 Years
ern
LV Geometric Pattern on Follow-Up
Normal
Geometry
Concentric
Remodeling
Eccentric
Hypertrophy
Concentric
Hypertrophy
2,874) 68 (1,960) 20 (559) 8 (228) 4 (127)
(n ¼ 820) 53 (437) 34 (279) 6 (47) 7 (57)
(n ¼ 590) 47 (274) 13 (78) 32 (189) 8 (49)
(n ¼ 208) 29 (60) 17 (36) 19 (39) 35 (73)
number of observations.higher level of BP and BMI at baseline were also asso-
ciatedwith lower odds of reverting to normal geometry
on follow-up. Thus, participants who were female,
younger, and with lower systolic BP and BMI at base-
line were more likely to revert to a normal LV pattern
on follow-up (Online Table 3).
ASSOCIATION OF CHANGE IN LEFT VENTRICULAR
GEOMETRY WITH INCIDENT CARDIOVASCULAR
DISEASE (MYOCARDIAL INFARCTION, HEART FAILURE,
AND DEATH FROM CORONARY HEART DISEASE).
In this sample, there were 2,105 observations
describing the change in LV geometry from exami-
nation cycles 5 to 6 (Table 4). Of these observations,
1,058 participants remained in the category of normal
geometry or concentric remodeling (referent cate-
gory), 439 participants improved and 479 worsened.
Participants who remained in the concentric or
eccentric hypertrophy group at cycle 6 (n ¼ 129)
(Table 4) were considered as a separate group as noted
earlier. The median follow-up time was 12.0 years,
and the total exposure time was 23,725.1 person-
years. The unadjusted incidences of CVD (composite
of myocardial infarction, heart failure, and death from
CHD) were 4.2% (reference category), 7.1% (improved
LV geometry), 9.0% (worsened LV geometry), and
17.1% (high-risk category) (Table 5). In age- and sex-
adjusted models, worsening of the LV geometry was
associated with an increased risk of CVD (Table 5).
As expected, participants who remained in the
eccentric or concentric hypertrophy groups had the
highest CVD risk. Analyses using ASE cut-points
revealed comparable results (Online Table 4).
Because of the relatively small number of participants
(n ¼ 129) and events (n ¼ 22) (Tables 4 and 5), no
subgroup analyses within the high-risk group could
be performed.
DISCUSSION
PRINCIPAL FINDINGS. In this community-based
cohort of middle-aged to older adults, the authors
observed dynamic changes in LV geometry fre-
quently. The key ﬁndings are summarized here. First,
the proportion of participants who changed their LV
geometric pattern depended on the baseline LV
geometry. Two-thirds of participants with normal
geometry at baseline remained in the same category,
whereas only approximately one-third of participants
with other geometric patterns remained in the same
baseline category (diagonal in Table 2). Reversal to
normal geometry was the most common change in
participants with abnormal geometry at baseline.
Second, in participants with normal geometry or
concentric remodeling at baseline, progression to
TABLE 3 Multivariable-Adjusted ORs and 95% CIs for Different Geometric Pattern on Follow-Up for Participants With Normal
LV Geometry at Baseline (2,874 Observations)*
Baseline Category
Category on Follow-Up
Normal
Concentric Remodeling Concentric Hypertrophy Eccentric Hypertrophy
Normal Geometry OR (95% CI) p Value OR (95% CI) p Value OR (95% CI) p Value
Age, years Referent 1.39 (1.24–1.56) <0.0001 1.86 (1.48–2.34) <0.0001 1.10 (0.93–1.31) 0.27
Male Referent 1.12 (0.91–1.37) 0.28 3.25 (2.15–4.94) <0.0001 1.35 (1.01–1.80) 0.04
Systolic BP, mm Hg Referent 1.26 (1.10–1.43) 0.0006 1.72 (1.35–2.19) <0.0001 1.39 (1.15–1.68) 0.0007
Body mass index, kg/m2 Referent 1.01 (0.90–1.14) 0.82 2.01 (1.65–2.45) <0.0001 1.74 (1.50–2.01) <0.0001
D Systolic BP, mm Hg Referent 1.05 (0.94–1.17) 0.43 1.28 (1.06–1.55) 0.01 1.18 (1.01–1.37) 0.03
D Body mass index, kg/m2 Referent 1.03 (0.92–1.14) 0.65 1.18 (0.96–1.44) 0.11 1.12 (0.98–1.29) 0.10
Smoking status Referent 1.26 (0.99–1.61) 0.059 1.26 (0.76–2.08) 0.38 1.21 (0.84–1.74) 0.30
Diabetes Referent 1.84 (1.08–3.15) 0.03 1.51 (0.68–3.37) 0.31 1.39 (0.67–2.85) 0.38
Antihypertensive treatment Referent 1.17 (0.85–1.61) 0.35 0.93 (0.54–1.58) 0.78 1.23 (0.79–1.90) 0.36
*OR per 1-SD increment in continuous traits and presence versus absence of binary traits. Bold indicates p values <0.05.
BP ¼ blood pressure; CI ¼ conﬁdence interval; D ¼ change from the baseline examination to the follow-up examination; OR ¼ odds ratio.
TABLE 4 Transition Matrix of LV Geometric Pattern From Examination Cycle 5 to
Examination Cycle 6
Number of
Observations
Examination Cycle 6
Normal
Geometry
Concentric
Remodeling
Eccentric
Hypertrophy
Concentric
Hypertrophy Total
Examination cycle 5
Normal geometry 915* 215† 112† 46† 1,288
Concentric remodeling 259‡ 143* 33† 32† 467
Eccentric hypertrophy 92‡ 18‡ 87§ 15† 212
Concentric hypertrophy 42‡ 28‡ 26† 42§ 138
Total 1,308 404 258 135 2,105
*Participants with normal geometry or concentric remodeling at examinations 5 and 6 served as the referent
category for the analyses relating change in LV geometry (from examination 5 to examination 6) to incident CVD
(after examination 6). †A change to a more abnormal LV geometric pattern (“worsening”). ‡A change to a more
normal LV geometric pattern (“improvement”) over 4 years. §Participants with concentric hypertrophy or
eccentric hypertrophy at examinations 5 and 6 were treated as a separate group (“remained high risk”).
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875concentric or eccentric hypertrophy was rare. Tran-
sition from eccentric to concentric hypertrophy was
also relatively infrequent (8%), whereas progression
from concentric to eccentric hypertrophy occurred
in 19% of participants. Third, higher BP and greater
BMI along with older age and male sex were the
main clinical correlates of an adverse change in LV
geometry. Fourth, the development of abnormal LV
geometry was associated with increased risk of CVD
on follow-up. The use of ASE-deﬁned cut-points for
LV geometric patterns (Online Tables 1 and 4) yiel-
ded results essentially similar to those obtained
using empirical sex-speciﬁc percentiles for LVM and
RWT.
IN THE CONTEXT OF THE LITERATURE. Pattern of
change in left ventricular geometric pattern. Animal data
parallel these ﬁndings supporting progression of LV
geometry over time. Researchers noted that salt-
sensitive Dahl rats fed a high-salt diet had an initial
increase in LVM and RWT, followed by a decline in
RWT after week 13 (19). These rats changed from
concentric hypertrophy to eccentric hypertrophy and
ultimately to symptomatic heart failure over the
course of 20 weeks (11). Thus, there is substantial
experimental evidence for a temporal sequence of
concentric hypertrophy leading to eccentric hyper-
trophy and eventually to the development of clinical
heart failure.
However, data in humans on the development of
LV geometric pattern over time are relatively scarce
and were predominantly derived from select sub-
samples of the population, such as patients with hy-
pertension (20,21) or older patients (22), as detailed
later.Patients with hypertension and electrocardio-
graphic evidence of LVH were part of the LIFE
(Losartan Intervention For Endpoint reduction in
hypertension) study, which reported the change in LV
geometric pattern after 1 year of antihypertensive
treatment (20). Consistent with the observations
from the present analysis, progression from normal
geometry or concentric remodeling to eccentric or
concentric hypertrophy was rare in the LIFE study
(20). Moreover, progression from concentric to
eccentric hypertrophy was observed in approximately
one-third of the moderately hypertensive patients in
the LIFE sample (20), whereas this proportion was
lower (19%) in this sample from the community. In
line with the authors’ observations, progression to
eccentric hypertrophy was similarly relatively infre-
quent, and regression to normal geometry was
TABLE 5 Crude Event Rates, and Age- and Sex-Adjusted Hazard Ratios for Incident
CVD/CHD Death (After Cycle 6) According to the Pattern of Change in LV Geometry
(From Cycle 5 to 6)
Change in LV Geometry
From Examination 5
to Examination 6
Events After
Examination 6/
Participants at Risk Risk (%)
Age- and
Sex-Adjusted
HR (95% CI) p Value
Reference 44/1,058 4.2 1.00
Improved 31/439 7.1 1.39 (0.88, 2.21) 0.16
Worsened 43/479 9.0 1.59 (1.04, 2.43) 0.03
High risk (remained EH/CH*) 22/129 17.1 3.42 (2.04, 5.74) <0.0001
*Participants with eccentric hypertrophy at examination 5 and examination 6 or with concentric hypertrophy
at examination 5 and examination 6.
CH ¼ concentric hypertrophy; CHD ¼ coronary heart disease; CI ¼ conﬁdence interval; CVD ¼ cardiovascular
disease; EH ¼ eccentric hypertrophy; HR ¼ hazard ratio; LV ¼ left ventricular.
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876relatively common in older participants from the
Cardiovascular Health Study (mean age 73 years)
with concentric geometry at baseline (22). Thus,
some evidence in these data supports a sequence
(as described in experimental models) of a change
from concentric remodeling to concentric hypertro-
phy and then to eccentric hypertrophy, even in the
absence of interim CVD events. However, such a
transition was observed in only a modest proportion
of participants. It is also conceivable that transitions
occurring during the 4-year period of follow-up may
have been missed in this investigation.
Most participants who changed from concentric to
eccentric hypertrophy in this sample displayed larger
LVEDD on follow-up as compared with the baseline
examination. This ﬁnding suggests that this change in
LV geometry was likely driven by LV dilation.
Another interesting observation in the present
data is that changes in LV geometry were relatively
common when participants had abnormal baseline
geometry. Only one-third of the participants with
abnormal geometry remained in the same category
(diagonal in Table 2). Approximately 29% to 53% of
participants with abnormal geometry at baseline had
normal geometry on follow-up. These ﬁndings are in
agreement with results from the LIFE study (20), and
they likely reﬂect the phenomenon of “regression to
the mean” (23). Furthermore, they are consistent with
the dynamic nature of LV geometry over time with
the potential for reversibility.
Clinical correlates of changes in left ventricular geometric
patterns. Overall, BP, BMI, age, and sex were the key
correlates of change in LV geometry over the 4-year
period. Older age, male sex, and higher baseline
levels of BP and BMI were associated with increased
odds of developing abnormal geometry on follow-up
and with lower odds of regression to normal LV
geometry. Among participants with abnormal LVgeometry at baseline, those who were female,
younger, and with lower systolic BP and BMI at
baseline were more likely to revert to a normal
LV pattern on follow-up (Online Table 3). These
observations are in excellent agreement with data
from cross-sectional and longitudinal studies on
population-based samples (6,15,24–26). Overall, these
data emphasize the importance of controlling CVD
risk factors to prevent worsening of LV geometry and
to reduce the associated risk of CVD.
Change in left ventricular geometry and risk of subsequent
cardiovascular disease. Considerable evidence indicates
that alterations in LV structure predict the incidence
of heart failure and other forms of CVD (3,4,27–28). In
an earlier report, Framingham investigators observed
that participants with concentric hypertrophy,
particularly men, had an increased risk of death and
incident CVD. These associations were attenuated on
adjustment for LVM and traditional risk factors (5).
However, this latter report did not describe the
pattern of change in LV geometry or the prognostic
signiﬁcance of change in LV geometry over time
(5). In African Americans, concentric hypertrophy
was strongly associated with diastolic dysfunction,
whereas eccentric hypertrophy was strongly associ-
ated with systolic dysfunction in cross-sectional an-
alyses (6). Similarly, higher LVM was associated with
an increased risk of developing a reduced ejection
fraction (<55%) on follow-up in older participants
(age $65 years) from the community (29). When
considering the LV geometric pattern in these par-
ticipants, mainly eccentric LVH, but not concentric
LVH, predicted the development of a low ejection
fraction (29). In clinical samples of patients with
concentric LVH at baseline, between 13% and 20%
developed a reduced ejection fraction or systolic
dysfunction during short-term follow-up (21,30,31).
Consistent with the previously mentioned reports,
the present analyses demonstrated that the devel-
opment of an abnormal LV geometric pattern was
associated with increased risk of subsequent CVD,
including heart failure, myocardial infarction, and
death from CHD. Even participants whose LV ge-
ometry improved over 4 years had an increased risk
of subsequently developing CVD compared with
the referent group (Table 5 and Online Table 4),
consistent with the notion that abnormal LV geom-
etry in the past continues to confer an adverse
prognosis.
STUDY LIMITATIONS. The strengths of this investi-
gation include the availability of a large number of
echocardiographic observations and the community-
based, prospective design. Limitations include
unavoidable biases resulting from differential
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877missingness and availability of echocardiographic
data by baseline LV geometric pattern, regression to
the mean, and misclassiﬁcation caused by changes in
the echocardiographic equipment over time and by
intrareader temporal drift. However, the authors have
implemented several quality control procedures in
the echocardiography laboratory (as detailed in the
Online Appendix) to monitor reproducibility of mea-
surements and temporal trends in measurements.
The categorization of LV geometry is based on
ratios of individual measurements that are sensitive
to measurement error, and such error can lead to
miscategorization. However, the authors expect this
misclassiﬁcation to be nondifferential (not related to
LV geometry or incident CVD or death from CHD),
thereby slightly reducing the statistical power of
these analyses and less likely to introduce a system-
atic error.
Regardless of such factors, unfavorable changes
in LV geometry were associated with an adverseprognosis. The generalizability of these observations
to other ethnicities is unknown.
CONCLUSIONS
In this prospective study of a large community-based
sample, the authors observed dynamic changes in LV
geometry over a 4-year period and identiﬁed older
age, male sex, higher BP, and greater BMI as key
clinical correlates of such change. Worsening of LV
geometry was associated with an adverse prognosis.
Although observational, these ﬁndings provide sup-
port for the importance of control of CVD risk factors
to prevent worsening of LV geometry and, in turn,
reduce the risk of future CVD.
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